SEC Form 4 · accession 0001209191-15-067013
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul J Hastings
Director
Period of report
Aug 17, 2015
Accepted (ET)
Aug 19, 2015 · 8:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2015 | M | 3,000 | $10.81 | A | 5,853 | D | |
| Common Stock | Aug 17, 2015 | S | 3,000 | $60.02 | D | 2,853 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $10.81 | Aug 17, 2015 | M | 3,000 | D | — | Jun 4, 2022 | Common Stock | 3,000 | 4,000 | D |
Explanation of responses
- F1The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- F2The stock options vest and become exercisable in twelve equal monthly installments beginning on July 5, 2012.